James Watson
Board Member @ Genesis Molecular AI
United States
Larkspur
Biotechnology
Corporate Development, Private Equity, Biotechnology, Investment Banking, Pharmaceuticals, Marketing and Commercial Planning, Lifesciences, Strategy, Due Diligence, Commercialization, Business Strategy, Venture Capital, Business Development, Licensing, Management, Competitive Analysis, Pharmaceutical Industry, Start-ups, Mergers, Biopharmaceuticals
Experience
Board Member
Genesis Molecular AI
Board Member
Inceptive
Board Member
Scribe Therapeutics
Board Member BioLabs (RBL)
Rice University
Board role advising early stage biotech companies emerging from Rice University on strategy, financing and business development.
Operating Partner & Head Business and Corporate Development Life Sciences Portfolio
Andreessen Horowitz
Menlo Park, California, United States
Operating Partner leading a16z's Bus. & Corporate Development team in Life Sciences. Strategic advisory role for portfolio companies covering Business Development, M&A and capital raising activities. Member of the Board of Directors for Genesis Therapeutics, Inceptive and Scribe Therapeutics. Also co-managing a16z's senior big pharma relationships including our $500m Ecosystem fund where Lilly is the sole LP.
Chief Business Officer
Carmot Therapeutics, Inc.
Berkeley, California, United States
Led strategic planning, finance, business and corporate development. Raised over $200m including $160m Series D in July 2022 for metabolic focused biotech company with a broad pipeline and a drug discovery platform.
Chief Business Officer and President ICT
Sigilon Therapeutics, Inc.
Cambridge, MA
Led Business and Corporate Development and a significant business unit. Recruited and managed a dedicated R&D team, acquired new cell therapy technology and managed major Alliance with Lilly
Chief Business Officer
Sigilon Therapeutics, Inc.
Cambridge, MA
Led Corporate Development and Financing for private biotech company based on ground breaking technology developed at MIT. Closed strategic partnership with Eli Lilly to develop functional cure for diabetes.
Chief Business Officer
Alvine Pharmaceuticals Inc
Head of Corporate Development, Financing, Commercial Planning and IP management. Closed option for AbbVie to acquire the Company.
Managing Director and Head of Investment Banking
Burrill & Company
CEO of Investment Banking and sat on Corus Board of Directors. Recruited and led the group and spent nearly 10 years advising therapeutic companies on major strategic partnerships, M&A and financing.
SVP Corporate Development and Marketing
Incyte
Head of Corporate Development, Strategic Planning and Commercial team of 30
Education
Indiana University - Kelley School of Business
Marketing
University of Portsmouth
Economics
James Watson's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.